BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9226243)

  • 1. Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
    Hironaka K; Mizushima M; Tsuzi C; Makino H
    Nephron; 1997; 76(3):358-9. PubMed ID: 9226243
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
    Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 5. The management of leprosy.
    Boughton CR; Lloyd AR
    Med J Aust; 1987 Jun; 146(11):593-9. PubMed ID: 3302636
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus.
    Pai S; Munshi R; Nayak C
    Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
    Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
    J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
    [No Abstract]   [Full Text] [Related]  

  • 12. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
    Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
    Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone-induced photosensitivity: a rare clinical presentation.
    Kar BR
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M; Chhetia R
    Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drugs used in tuberculosis and leprosy].
    Aoyagi T; Toyoda T
    Nihon Rinsho; 1990 Oct; 48(10):2212-7. PubMed ID: 2280466
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone syndrome.
    Dhamija R; Kumar D; Khurana G
    Trop Doct; 1995 Oct; 25(4):176-7. PubMed ID: 7502329
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid.
    Hegarty AM; Ormond M; Sweeney M; Hodgson T
    Eur J Dermatol; 2010; 20(2):223-4. PubMed ID: 20123643
    [No Abstract]   [Full Text] [Related]  

  • 19. Methemoglobinemia and dapsone levels in patients with leprosy.
    Vieira JL; Riveira JG; Martins Ade N; Silva JP; Salgado CG
    Braz J Infect Dis; 2010; 14(3):319-21. PubMed ID: 20835521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
    Kaur J; Khandpur S; Seith A; Khanna N
    Indian J Lepr; 2005; 77(3):267-71. PubMed ID: 16353525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.